Kappa 2 opioid receptors inhibit NMDA receptor-mediated synaptic currents in guinea pig CA3 pyramidal cells
Authors:
Open Access
- 1 September 1994
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 14 (9) , 5580-5589
Abstract
The role of the endogenous opioid peptide dynorphin (1–17) in regulating NMDA receptor-mediated synaptic currents was examined in guinea pig hippocampus. Schaffer collateral/commissural fiber-evoked NMDA synaptic currents were recorded using whole-cell patch-clamp techniques in CA3 pyramidal cells. Dynorphin was found to have dual effects on NMDA synaptic currents, increasing currents at low concentrations and decreasing currents at high concentrations. Only the inhibitory action of dynorphin was sensitive to naloxone, indicating that this effect was mediated by an opioid receptor. The inhibitory effect was mimicked by bremazocine, but not by U69,593, U50,488, [D- Ala2, N-Me-Phe4, Gly-ol]-enkephalin, or [D-Pen2,5]-enkephalin. Bremazocine's effect was blocked by naloxone, but not by nor- binaltorphimine, cyprodime, or naltrindole. These findings suggest that bremazocine's effect was mediated by the kappa 2 subtype of opioid receptor. In addition, 1 microM naloxone and antisera to dynorphin (1– 17) were found to increase NMDA-mediated synaptic currents. Nor- binaltorphimine, cyprodime, naltrindole, and antisera to met-enkephalin did not increase the NMDA synaptic current. These findings suggest that endogenous dynorphin was acting at kappa 2 receptors to inhibit NMDA receptor-mediated synaptic currents. Overall, these findings indicate that dynorphin is an endogenous agonist for kappa 2 receptors in the CA3 region of the guinea pig hippocampus and that these receptors regulate NMDA receptor function.Keywords
This publication has 39 references indexed in Scilit:
- [3H]Naltrindole: a potent and selective ligand for labeling δ-opioid receptorsBrain Research, 1993
- Selective involvement of kappa opioid and phencyclidine receptors in the analgesic and motor effects of dynorphin-A-(1–13)-Tyr-Leu-Phe-Asn-Gly-ProBrain Research, 1992
- Selective potentiation of NMDA-induced activity and release of excitatory amino acids by dynorphin: possible roles in paralysis and neurotoxicityBrain Research, 1992
- Competitive and non-competitive NMDA antagonists limit dynorphin A-induced rat hindlimb paralysisBrain Research, 1990
- A novel interaction between dynorphin(1–13) and an N-methyl-d-aspartate siteBrain Research, 1988
- Effects of selective and non-selective ℵ-opioid receptor agonists on cutaneous C-fibre-evoked responses of rat dorsal horn neuronesBrain Research, 1987
- Distribution of opiate receptor subtypes and enkephalin and dynorphin immunoreactivity in the hippocampus of squirrel, guinea pig, rat, and hamsterJournal of Comparative Neurology, 1987
- Increased enkephalin and dynorphin immunoreactivity in the hippocampus of seizure sensitive Mongolian gerbilsBrain Research, 1987
- Endogenous opioid immunoreactivity in rat spinal cord following traumatic injuryAnnals of Neurology, 1985
- Localization of enkephalin‐like immunoreactivity to identified axonal and neuronal populations of the rat hippocampusJournal of Comparative Neurology, 1981